Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 1/20 | 0.58 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.53 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 4/20 | 0.52 |
| ▸ | CTSS | P25774 | 2/20 | 0.52 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18789049 | 0.91 | CAPN1 (0.63) | CAPN1CAPN2CTSKCTSSCTSL | |
| SCHEMBL18806289 | 0.90 | FOLH1 (0.58) | CPB1CPB2FOLH1CA1CA2 | |
| SCHEMBL23348289 | 0.88 | FOLH1 (0.60) | CPB1CPB2FOLH1CA1CA2 | |
| SCHEMBL18806287 | 0.87 | FOLH1 (0.59) | CPB1CPB2FOLH1CA1CA2 | |
| SCHEMBL17244715 | 0.85 | SIRT5 (0.62) | FOLH1 | |
| SCHEMBL18789040 | 0.85 | FOLH1 (0.57) | CPB1CPB2FOLH1CA1CA2 | |
| SCHEMBL26222682 | 0.85 | CA1 (0.61) | CPB1CPB2FOLH1CA1CA2 | |
| SCHEMBL24130284 | 0.83 | CPB1 (0.66) | CPB1CPB2FOLH1CAPN1CAPN2 | |
| SCHEMBL24130289 | 0.83 | CPB1 (0.66) | CPB1CPB2FOLH1CAPN1CAPN2 | |
| SCHEMBL17694108 | 0.83 | SIRT2 (0.68) | CTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170119841-A1 | AMINO ACID SALTS OF UNSATURATED FATTY ACIDS | THETIS PHARMACEUTICALS LLC | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119841-A1 | AMINO ACID SALTS OF UNSATURATED FATTY ACIDS | SLC27A2, SLC27A1, SLC1A5 | CPB1 2641/4885CPB2 1712/4885FOLH1 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.